Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole

Adrián Martínez-Meléndez, Laura Tijerina-Rodríguez, Nathania Collins, Simon D. Baines, Rayo Morfin-Otero, Adrián Camacho-Ortíz, Licet Villarreal-Treviño, Elvira Garza-González*

*Autor correspondiente de este trabajo

Producción científicarevisión exhaustiva

Resumen

In this study, we report the results of the epidemiological analysis of Clostridioides difficile ribotypes (RTs) and antimicrobial susceptibility testing. Most isolates were RT027, representing 73% (84/115) of isolates. No isolates with reduced susceptibility to fidaxomicin were found; however, 38 (33.04%) isolates had reduced susceptibility to metronidazole, and 7 isolates (6.1%) had reduced susceptibility to vancomycin. These findings highlight the need for continuous surveillance of C. difficile RTs and antimicrobial susceptibility testing.

Idioma originalEnglish
Páginas (desde-hasta)1672-1676
Número de páginas5
PublicaciónMicrobial Drug Resistance
Volumen27
N.º12
DOI
EstadoPublished - dic 2021
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© Copyright 2021, Mary Ann Liebert, Inc., publishers 2021.

All Science Journal Classification (ASJC) codes

  • Microbiología
  • Inmunología
  • Farmacología
  • Microbiología (médica)

Huella

Profundice en los temas de investigación de 'Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole'. En conjunto forman una huella única.

Citar esto